Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 25908727)

Published in Circ Res on April 24, 2015

Authors

Mary McGrae McDermott1

Author Affiliations

1: From the Departments of Medicine and Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. mdm608@northwestern.edu.

Associated clinical trials:

Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD) (PROPEL) | NCT01408901

Articles cited by this

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care (1996) 70.87

Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA (2001) 13.65

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation (2006) 13.21

The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ (1962) 10.43

Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc (2006) 8.75

Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84

Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet (2013) 7.03

Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13

Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation (1993) 4.75

Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol (1991) 4.67

Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA (2004) 4.27

Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA (2001) 3.90

Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA (2009) 3.83

Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation (2012) 3.39

The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med (2002) 3.32

Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation (2009) 3.28

The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med (1996) 2.85

Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism. J Am Coll Cardiol (2009) 2.81

Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am J Epidemiol (2005) 2.75

Risk of mortality and cardiovascular disease associated with the ankle-brachial index: Systematic review. Atherosclerosis (2006) 2.74

The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.62

ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol (1996) 2.46

Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study. Circulation (2000) 2.18

Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease. Circulation (2014) 2.03

Physical activity during daily life and mortality in patients with peripheral arterial disease. Circulation (2006) 2.02

The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease. Circulation (2014) 1.95

Lower extremity ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease. J Am Geriatr Soc (2007) 1.92

Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle. J Vasc Surg (2000) 1.83

Prognostic value of functional performance for mortality in patients with peripheral artery disease. J Am Coll Cardiol (2008) 1.82

Baseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease. J Am Coll Cardiol (2007) 1.67

Axonal neuropathy in chronic peripheral arterial occlusive disease. Muscle Nerve (2002) 1.59

The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation (1985) 1.52

The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction. Vasc Endovascular Surg (2008) 1.45

The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type. Vasc Endovascular Surg (2008) 1.45

Intermittent claudication: its natural course. Surgery (1975) 1.43

Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA (2013) 1.35

The natural course of arteriosclerosis of the lower extremities. Proc R Soc Med (1962) 1.34

Mitochondrial defects and oxidative damage in patients with peripheral arterial disease. Free Radic Biol Med (2006) 1.34

Physical activity during daily life and functional decline in peripheral arterial disease. Circulation (2008) 1.34

Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease. Arch Intern Med (1999) 1.31

Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA (2012) 1.29

Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc (2002) 1.26

Intermittent claudication. Incidence in the Framingham Study. Circulation (1970) 1.18

The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease. Am Heart J (2004) 1.16

Abnormal mitochondrial respiration in skeletal muscle in patients with peripheral arterial disease. J Vasc Surg (2003) 1.16

Lower extremity nerve function in patients with lower extremity ischemia. Arch Intern Med (2006) 1.14

The fate of patients with intermittent claudication managed nonoperatively. Am J Surg (1976) 1.12

Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation (2008) 1.12

Pathophysiological changes in calf muscle predict mobility loss at 2-year follow-up in men and women with peripheral arterial disease. Circulation (2009) 1.12

Chronically ischemic mouse skeletal muscle exhibits myopathy in association with mitochondrial dysfunction and oxidative damage. Am J Physiol Regul Integr Comp Physiol (2008) 1.07

Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial. J Am Heart Assoc (2014) 1.02

Mitochondriopathy of peripheral arterial disease. Vascular (2007) 1.00

Skeletal muscle mitochondrial ATP production rate and walking performance in peripheral arterial disease. Clin Physiol Funct Imaging (2002) 0.96

Oxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial disease. J Transl Med (2013) 0.96

Mitochondrial function and oxygen supply in normal and in chronically ischemic muscle: a combined 31P magnetic resonance spectroscopy and near infrared spectroscopy study in vivo. J Vasc Surg (2001) 0.94

Femoral nerve conduction in diabetes and chronic occlusive vascular disease. J Neurol Neurosurg Psychiatry (1968) 0.93

Calf muscle adaptation to peripheral vascular disease. Cardiovasc Res (1985) 0.93

Women with peripheral arterial disease experience faster functional decline than men with peripheral arterial disease. J Am Coll Cardiol (2011) 0.93

Exercise performance in patients with peripheral arterial disease who have different types of exertional leg pain. J Vasc Surg (2007) 0.92

Peripheral arterial disease symptom subtype and walking impairment. Vasc Med (2005) 0.92

The role of comorbidity in the assessment of intermittent claudication in older adults. J Clin Epidemiol (2001) 0.89

Calf muscle adaptation in intermittent claudication. Side-differences in muscle metabolic characteristics in patients with unilateral arterial disease. Clin Physiol (1988) 0.89

The effect of ischemia reperfusion injury on skeletal muscle. Injury (2011) 0.89

A comparative study of peripheral nerve conduction in diabetes and non-diabetic chronic occlusive peripheral vascular disease. Brain (1969) 0.89

Leg symptom categories and rates of mobility decline in peripheral arterial disease. J Am Geriatr Soc (2010) 0.88

Abnormal muscle mitochondria in ischemic claudication. Acta Neurol Belg (1987) 0.87

Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication. J Vasc Interv Radiol (2013) 0.86

Histochemical changes in striated muscle in patients with intermittent claudication. Arch Pathol Lab Med (1977) 0.86

The demographics of claudication and the aging of the American population. Vasc Med (1996) 0.84

Lower extremity nerve function, calf skeletal muscle characteristics, and functional performance in peripheral arterial disease. J Am Geriatr Soc (2011) 0.82

Function of fast- and slow-twitch rat skeletal muscle following ischemia and reperfusion at different intramuscular temperatures. Eur Surg Res (2000) 0.82

The PADQOL: development and validation of a PAD-specific quality of life questionnaire. Vasc Med (2012) 0.78

The association between peripheral artery and lumbar spine disease: a single-center study. Am J Med (2012) 0.76